UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000017930
Receipt No. R000020785
Scientific Title Multinational comparison analysis using quantitative radiological evaluation in MAC pulmonary disease (MACPD)
Date of disclosure of the study information 2015/06/17
Last modified on 2020/06/19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Multinational comparison analysis using quantitative radiological evaluation in MAC pulmonary disease (MACPD)
Acronym Quantitative radiological evaluation in MACPD
Scientific Title Multinational comparison analysis using quantitative radiological evaluation in MAC pulmonary disease (MACPD)
Scientific Title:Acronym Quantitative radiological evaluation in MACPD
Region
Japan Asia(except Japan) North America
Australia Europe

Condition
Condition Mycobacterium avium complex pulmonary disease (MAC-PD)
Classification by specialty
Pneumology Radiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The aim of this study is to reveal the relation between clinical cure, radiological cure and microbiological cure and to clarify the ability to predict who will be cured based on CT scoring system.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes We will detect the change of the severity scores of MAC diseases by chest X-ray and CT scan, before and after 12 months of therapy, from cases in 3 or more countries.
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Adult patients with MACPD (i.e. microbiologically confirmed M. avium or M. intracellulare) from each country that were diagnosed according to 2007 ATS/IDSA guideline since 2007. Chest X-ray and plain CT that have been performed each before and one year and optionally 6 months after starting a standard treatment recommended by the ATS/IDSA will be collected.
Key exclusion criteria HIV-1 positive or patients taking immunosuppressive drugs. Under 18 year-old. Clarithromycin resistant case.
Target sample size 90

Research contact person
Name of lead principal investigator
1st name Kozo
Middle name
Last name Morimoto
Organization Fukujuji Hospital,
Japan Anti-Tuberculosis Association
Division name Respiratory Disease Center
Zip code 204-8522
Address 3-1-24 Matsuyama 204-8522 Kiyose-shi, Tokyo, Japan
TEL 81-42-491-4111
Email morimotok@fukujuji.org

Public contact
Name of contact person
1st name Kozo
Middle name
Last name Morimoto
Organization Fukujuji Hospital, Japan Anti-Tuberculosis Association
Division name Respiratory Disease Center
Zip code 204-8522
Address 3-1-24 Matsuyama 204-8522 Kiyose-shi, Tokyo, Japan
TEL 81-42-491-4111
Homepage URL
Email morimotok@fukujuji.org

Sponsor
Institute NTM-NET (NONTUBERCULOUS MYCOBACTERIA NETWORK EUROPOEAN TRIALGROUP)
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Fukujuji Hospital
Address 3-1-24. Matsuyama Kiyose-city
Tel 0424914111
Email bxypb621@ybb.ne.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 06 Month 17 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 80
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2015 Year 01 Month 24 Day
Date of IRB
2015 Year 06 Month 09 Day
Anticipated trial start date
2015 Year 06 Month 20 Day
Last follow-up date
2022 Year 06 Month 15 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Enrolling by Invitation

Management information
Registered date
2015 Year 06 Month 16 Day
Last modified on
2020 Year 06 Month 19 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020785

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.